Should you invest in CRISPR Therapeutics (CRSP +0.18%) before the end of the year? The company's shares have slightly underperformed the broader market to date, but the biotech ma ...

Within the utilities sector, short interest at the end of August was spread broadly across the sector, with no single industry emerging as a clear standout or dominating in terms of positioning.

TV y streaming online de la semifinal de la Leagues Cup 2026 Toda la información sobre el Toluca contra León de la Leagues Cup 2026. The Sporting News Leagues Cup 2026: Resultados, posiciones, ...

Typewriter Therapeutics has emerged from stealth with $56 million in Series A funding co-led by AN Venture Partners and RA Capital Management, with participation from ANRI, Gemseki and SBI US Gateway ...

Editas Medicine (EDIT) stays a Hold as EDIT-401 nears trials; preclinical 90%+ LDL-C reduction for HeFH, but dilution and competition loom—read more macroanalysis here.

More foldables are set to use the display technology of the foldable iPhone.

Typewriter Therapeutics secures $56M Series A to develop in vivo CAR T gene therapy using non-viral RNA platform. Discover the breakthrough.

Budget phone shoppers in India just got another price hike to deal with. Vivo and its sub-brand iQOO have raised the prices ...

Vivo will officially unveil OriginOS 7, the next major update for its smartphones,  at its 2026 Vivo Developer Conference on ...

Vivo T5 debuts in India with a 6.83-inch 144Hz AMOLED screen, 7,050mAh battery, and Dimensity 7500 Turbo chip. It starts at ₹34,999 and launches on Sept 9.

Vivo has unveiled the Vivo T5 5G in India, featuring a massive 7,050mAh battery and a 144Hz curved AMOLED display. Prices ...

Vivo has launched its new T5 smartphone in India on Wednesday, September 2. With a starting price of Rs 34,999, the ...